Clinical Trial Detail

NCT ID	NCT01638676
Title	A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Recruitment	Unknown status
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	James Graham Brown Cancer Center
Indications	melanoma
Therapies	Metformin + Vemurafenib
Age Groups:	adult